Adimmune Corporation (TPE:4142)
Taiwan
· Delayed Price · Currency is TWD 17.55
+0.05 (0.29%)
Jun 6, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Adimmune | 1.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Adimmune Growth | -15.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Enimmune | 43.49M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Enimmune Growth | -76.87% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Serum Vaccines, Western Medicine Products and Testing Reagents | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Serum Vaccines, Western Medicine Products and Testing Reagents Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Taiwan | 842.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan Growth | -12.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 477.56M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -24.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 326.82M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -5.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 138.28M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -56.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|